Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Woosung Pharm is a South Korean pharmaceutical company established in 1984, specializing in the manufacture and distribution of specialized medicinal products. The company is particularly recognized for its strength in the anesthesia and narcotics segment, producing generic versions of essential hospital drugs such as propofol, midazolam, and fentanyl. Beyond anesthetics, Woosung Pharm maintains a diverse portfolio covering circulatory, respiratory, and digestive system treatments. The company operates GMP-certified manufacturing facilities and focuses on providing high-quality essential medicines to the domestic Korean healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Woosung Pharma.